Insulet shares are trading lower after UBS cuts the price target from $270 to $215.
Portfolio Pulse from Benzinga Newsdesk
UBS has cut the price target for Insulet from $270 to $215, causing the company's shares to trade lower.
September 07, 2023 | 2:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Insulet's stock price is trading lower due to UBS's decision to cut its price target from $270 to $215.
The reduction in price target by UBS indicates a less optimistic outlook for Insulet, which has led to a decrease in the company's stock price. Investors may be selling shares due to the revised lower price target, causing the stock to trade lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100